Company intelligence / Profile preview
Rejuvenation Technologies
Mountain View, California, United Statesrejuvenationtech.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
The company has shown successful proof-of-concept rescue of multiple mouse models of liver and lung disease. Their technology can reportedly rewind 10 years of telomere shortening with a single dose, and has shown "remarkable efficacy" in preclinical models in both liver fibrosis and liver failure[6].
- Therapeutic areas
- ImmunologyPulmonologyGastroenterology
- Modalities
- mRNA therapeuticslipid nanoparticles (LNP)
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Kudo Biotechnology
Beyond the preview
Go deeper on Rejuvenation Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rejuvenation Technologies.